脑脊液中的16-mer低素-1/素-A用于诊断麻醉症
Vialaret Jerome1,2, Hirtz Christophe1,2, Lotierzo Manuela3
1LBPC-PPC, University of Montpellier, INM INSERM, IRMB CHU de Montpellier, Montpellier, France.
Sleep
|August 13, 2025
概括
在脑脊液中发现了一种新型的16-mer orexin-A片段,该片段对诊断1型麻醉症 (NT1) 是有前途的. 液体染色体质谱法 (LC-MS) 对睡眠障碍中的这种生物标志物提供了比放射性免疫检测 (RIA) 更好的准确性.
科学领域:
- 神经科学是一个神经科学.
- 睡眠医学 睡眠医学
- 生物标志物发现发现
背景情况:
- 通过放射性免疫检测 (RIA) 测量脑脊液 (CSF) 低-1/素-A 是诊断1型麻醉症 (NT1) 的标准.
- 由于RIA的局限性,需要探索NT1和其他高睡眠障碍的替代,更精确的诊断方法.
研究的目的:
- 通过已建立的RIA方法检测到的使用液体染色学质谱法 (LC-MS) 充分表征CSF素-A片段.
- 评估在患有NT1,2型麻醉症 (NT2),异常性高睡眠症 (IH) 和非指定的高睡眠症 (NSH) 患者中量化特定的16-mer素-A片段的诊断相关性.
主要方法:
- 分析了来自115名患有高睡眠障碍的患者的CSF样本,使用RIA和LC-MS.
- 通过分离技术和向质谱法 (MS) 隔离和识别素-A及其碎片.
- 在诊断准确性方面,LC-MS性能与RIA的统计比较.
主要成果:
- 通过LC-MS识别和量化了16-mer素-A片段,在NT1患者中显示出明显较低的水平.
- 这种16-米尔片段与RIA测量的素-A (r=0.83,p<.0001) 有着强烈的相关性.
- 在NT1诊断中,16-mer片段获得了高灵敏度 (98.1%) 和特异性 (85.7%),最佳切线为10.67 pg/mL (AUC=0.975).
结论:
- 16米尔甲素-A是诊断中心高睡眠障碍的潜在生物标志物.
- 过渡到LC-MS用于16-mer素-A量化,代表了对睡眠障碍的诊断准确性的重大进步.
- 这种方法增强了对麻醉症等疾病中色功能障碍的理解.
更多相关视频
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
7.9K
05:43Real-Time Dynamic Collection of Hippocampal Extracellular Fluid from Conscious Rats Using a Microdialysis System
Published on: October 21, 2022
2.6K
相关概念视频
Sleep-Wake Cycles
1.6K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.6K
Narcolepsy
197
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
197
Management of Insomnia
322
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
322
REM Sleep Behavior Disorder
405
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
405
Olfaction
45.2K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
45.2K
